Saving Billions & Driving Innovation: The 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth Agreement
Last week, during the Autumn statement, it was announced that a monumental agreement had been made between the government, National Health Service (NHS) and pharmaceutical industry that would revolutionise access to life-saving treatment and drive innovation and development in the UK life sciences industry. This deal comes as part of the voluntary scheme for branded […]